HeartSciences (HSCS) Change in Account Payables (2021 - 2026)
HeartSciences' (HSCS) quarterly Change in Account Payables came in at -$92400.0 in Q2 2026, down 6.93% YoY from -$99275.7 in Q2 2025, and down 370.45% on a QoQ basis from $34165.0 in Q4 2025.
HeartSciences (HSCS) Change in Account Payables (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has 6 years of Change in Account Payables data on file, last reported at -$92400.0 in Q2 2026.
- Quarterly Change in Account Payables fell 6.93% year-over-year to -$92400.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$180086.0 (down 39.04% YoY) and the FY2026 annual result came in at -$334.0, up 99.74% from the prior year.
- Change in Account Payables retreated to -$92400.0 in Q2 2026, from $34165.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $633457.0 in Q4 2023 to a low of -$673221.0 in Q1 2024.
- A 5-year average of -$5888.4 and a median of -$35436.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 970.47% — and 2024, when it sank 374.31%.
- Tracing HSCS's Change in Account Payables over 5 years: stood at $339522.0 in 2022, then jumped by 86.57% to $633457.0 in 2023, then tumbled by 118.89% to -$119658.0 in 2024, then jumped by 128.55% to $34165.0 in 2025, then sank by 370.45% to -$92400.0 in 2026.
- The last three Change in Account Payables figures came in at -$92400.0 (Q2 2026), $34165.0 (Q4 2025), and -$35436.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | HeartSciences | 6.54 Mn | 4.84 Mn | - | -92,400.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -92,400.00 |
| Apr 30, 2026 | -92,400.00 |
| Oct 31, 2025 | 34,165.00 |
| Oct 31, 2025 | 34,165.00 |
| Jul 31, 2025 | -35,436.00 |
| Jul 31, 2025 | -35,436.00 |
| Apr 30, 2025 | -86,415.00 |
| Apr 30, 2025 | -86,415.00 |
| Jan 31, 2025 | 128,228.00 |
| Jan 31, 2025 | 128,228.00 |
| Oct 31, 2024 | -119,658.00 |
| Oct 31, 2024 | -119,658.00 |
| Jul 31, 2024 | -51,677.00 |
| Jul 31, 2024 | -51,677.00 |
| Apr 30, 2024 | 33,107.00 |
| Apr 30, 2024 | 33,107.00 |
| Jan 31, 2024 | -673,221.00 |
| Jan 31, 2024 | -673,221.00 |
| Oct 31, 2023 | 633,457.00 |
| Oct 31, 2023 | 633,457.00 |